Prodeon Medical, a privately held medical device company focused on advancing minimally invasive therapies for urologic diseases, today announced it has received U.S. Food and Drug Administration (FDA ...
Image courtesy of Prodeon Medical] Prodeon Medical announced today that it received FDA 510(k) clearance for its Urocross ...
MedPage Today on MSN
Non-Ablative Treatment for BPH/LUTS Achieves Rapid, Sustained Improvements
Results with Optilume consistent in clinical trials and real world, regardless of prostate ...
Medical Device Network on MSN
Prodeon Medical’s BPH implant gains FDA clearance
In data supporting FDA approval, 48.1% implanted with Prodeon’s Urocross saw International Prostate Symptom Score improvements.
Drug Used for Enlarged Prostate Tied to High Glaucoma Risk The use of alpha-blockers for benign prostatic hyperplasia is tied to an increased risk of developing acute angle-closure glaucoma, a study ...
The benefits of laser surgery vs TURP for BPH treatment vary among patients with stage 1-5 CKD. For patients with chronic kidney disease (CKD) undergoing a procedure for benign prostatic hyperplasia ...
Bipolar enucleation significantly reduced IPSS in men with large prostates and obstructed bladder necks, but the procedure led to a high rate of retrograde ejaculation. Bipolar enucleation of the ...
Before having Aquablation (water ablation) therapy, it is essential to check that the treatment, equipment, medical facility, and healthcare professional are Medicare-approved and that the person ...
Benign prostatic hyperplasia (BPH) is a condition that affects the prostate gland in men. It is characterized by an enlarged prostate which can cause urinary symptoms such as difficulty starting or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results